Neural‐Immune Interactions in Health and Disease
暂无分享,去创建一个
[1] Wolfgang Rauh,et al. Attenuated Free Cortisol Response to Psychosocial Stress in Children with Atopic Dermatitis , 1997, Psychosomatic medicine.
[2] J A Gustafsson,et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. , 1995, Molecular endocrinology.
[3] K. Madden,et al. Effects of l-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F344 rats , 1999, Journal of Neuroimmunology.
[4] A. Miller,et al. Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. , 1999, Journal of immunology.
[5] G. Chrousos,et al. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro , 1988, Brain Research.
[6] R. Dantzer,et al. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. , 1995, The American journal of physiology.
[7] G. Chrousos,et al. Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease , 1999, Trends in Endocrinology & Metabolism.
[8] Elaine F. Remmers,et al. A genome scan localizes five non–MHC loci controlling collagen–induced arthritis in rats , 1996, Nature Genetics.
[9] David A. Williams,et al. Murine interleukin‐11 (IL‐11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis , 1996, Journal of cellular physiology.
[10] R. Gomez-flores,et al. Suppression of Splenic Macrophage Functions Following Acute Morphine Action in the Rat Mesencephalon Periaqueductal Gray , 1999, Brain, Behavior, and Immunity.
[11] A. Kaneko,et al. Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[12] W. Banks,et al. Passage of cytokines across the blood-brain barrier. , 1995, Neuroimmunomodulation.
[13] C. Saper,et al. Mechanisms of CNS response to systemic immune challenge: the febrile response , 1997, Trends in Neurosciences.
[14] R. Dantzer,et al. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[15] K. Vedhara,et al. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination , 1999, The Lancet.
[16] P. Deuster,et al. Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1β (IL-1β), IL-6, and Tumor Necrosis Factor-α (TNFα) Production in Humans: High Sensitivity of TNFα and Resistance of IL-6 , 1997 .
[17] I. Campbell. Neuropathogenic actions of cytokines assessed in transgenic mice , 1995, International Journal of Developmental Neuroscience.
[18] G. Chrousos,et al. The Stress Response and the Regulation of Inflammatory Disease , 1992, Annals of Internal Medicine.
[19] D. Felten,et al. Corticosterone responses of adult Lewis and Fischer rats , 1997, Journal of Neuroimmunology.
[20] M. Weller,et al. Maturation‐dependent Modulation of Apoptosis in Cultured Cerebellar Granule Neurons by Cytokines and Neurotrophins , 1996, The European journal of neuroscience.
[21] J. Sheridan,et al. Stress-induced modulation of the primary cellular immune response to herpes simplex virus infection is mediated by both adrenal-dependent and independent mechanisms , 1993, Journal of Neuroimmunology.
[22] D. Payan. Neuropeptides and inflammation: the role of substance P. , 1989, Annual review of medicine.
[23] Jae-Wook Oh,et al. Interleukin-6 (IL-6) Production by Astrocytes: Autocrine Regulation by IL-6 and the Soluble IL-6 Receptor , 1999, The Journal of Neuroscience.
[24] M. Wong,et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation , 1996, Nature Medicine.
[25] S. Wiegand,et al. Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp , 1987, Journal of neuroscience research.
[26] P. Sawchenko,et al. Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.
[27] D. Mason,et al. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. , 1990, Immunology.
[28] E. O. Johnson,et al. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. , 1989, Endocrinology.
[29] D. Taub,et al. Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. , 1998 .
[30] G. Chrousos,et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[31] G. Chrousos,et al. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1β and αMSH: studies in rats with different susceptibility to inflammatory disease , 1993, Brain Research.
[32] S. Maier,et al. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. , 1995, Life sciences.
[33] E. Schmidt,et al. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[34] F. Dhabhar,et al. Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels — a comparison between Sprague-Dawley, Fischer 344 and Lewis rats , 1993, Brain Research.
[35] D. Pollen,et al. Altered expression of transforming growth factor-beta in Alzheimer's disease , 1995, Neurology.
[36] J. Sheridan,et al. Stress and immunity: implications for viral disease and wound healing. , 1999, Journal of periodontology.
[37] F. Dhabhar,et al. Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats , 1995, Journal of Neuroimmunology.
[38] G. Chrousos,et al. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. , 1991, Science.
[39] F. Holsboer,et al. Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis , 1999, Journal of Neurology.
[40] N. Rothwell,et al. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. , 1997, The Journal of clinical investigation.
[41] M. Yokoyama,et al. Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. , 1995, Neuroimmunomodulation.
[42] S. Pillemer,et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. , 1994, Arthritis and rheumatism.
[43] R. D. Mellon,et al. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity , 1998, Brain Research.
[44] L. Adorini,et al. IL-12 production by central nervous system microglia is inhibited by astrocytes. , 1997, Journal of immunology.
[45] R. Fässler,et al. The multi-factorial pathogenesis of autoimmune disease. , 1987, Immunology letters.
[46] S. Felten,et al. Parallel development of noradrenergic innervation and cellular compartmentation in the rat spleen , 1989, Experimental Neurology.
[47] D. Goldstein,et al. Role of CRH in Glucopenia‐lnduced Adrenomedullary Activation in Rats , 1993, Journal of neuroendocrinology.
[48] E. Sternberg,et al. Intracerebroventricular Transplantation of Embryonic Neuronal Tissue from Inflammatory Resistant into Inflammatory Susceptible Rats Suppresses Specific Components of Inflammation , 1997, Experimental Neurology.
[49] G. Glazner,et al. Interleukin-1 alpha and vasoactive interstinal peptide: Enigmatic regulation of neuronal survival , 1995, International Journal of Developmental Neuroscience.
[50] J. Sheridan,et al. Stress-induced changes attributable to the sympathetic nervous system during experimental influenza viral infection in DBA/2 inbred mouse strain , 1994, Journal of Neuroimmunology.
[51] K. Madden,et al. Catecholamine influences and sympathetic neural modulation of immune responsiveness. , 1995, Annual review of pharmacology and toxicology.
[52] Kenneth M. Murphy,et al. Functional diversity of helper T lymphocytes , 1996, Nature.
[53] G. Chrousos,et al. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. , 1990, Endocrinology.
[54] J. Satoh,et al. Interleukin‐15 gene expression in human astrocytes and microglia in culture , 1996, Neuroreport.
[55] G. Chrousos,et al. Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. , 1992, The Journal of rheumatology.
[56] G. Chrousos,et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[57] D. Murphy,et al. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. , 1989, Endocrinology.
[58] R. J. Omeljaniuk,et al. Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats. , 1994, Neuroimmunomodulation.
[59] R. Dantzer,et al. Molecular Basis of Sickness Behavior a , 1998, Annals of the New York Academy of Sciences.
[60] E. Sternberg,et al. Corticosteroid resistance and disease. , 1997, Annals of medicine.
[61] E. Goetzl,et al. Dual Roles of Substance P: Modulator of Immune and Neuroendocrine Functions a , 1987, Annals of the New York Academy of Sciences.
[62] T. Dinan,et al. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. , 1998, Life sciences.
[63] P. Munson,et al. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami , 1989, Peptides.
[64] E. Benveniste. Cytokines: influence on glial cell gene expression and function. , 1992, Chemical immunology.
[65] R. Holmdahl,et al. Estrogen-mediated immunosuppression in autoimmune diseases , 1998, Inflammation Research.
[66] G. Chrousos,et al. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1988, The Journal of clinical investigation.
[67] R. Dantzer,et al. Cytokines and Sickness Behavior , 1998, Annals of the New York Academy of Sciences.
[68] K. Madden,et al. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy , 1994, Journal of Neuroimmunology.
[69] R. Gaillard. Cytokines in the neuroendocrine system. , 1998, International reviews of immunology.
[70] J. Kiecolt-Glaser,et al. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. , 1998, The American journal of medicine.
[71] F. Bloom,et al. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. , 1997, Journal of immunology.
[72] M. Demitrack,et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.
[73] R. D. Mellon,et al. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. , 1999, The Journal of pharmacology and experimental therapeutics.
[74] N. Rothwell,et al. Cytokines and the nervous system I: expression and recognition , 1995, Trends in Neurosciences.
[75] W. Banks,et al. Relative contributions of peripheral and central sources to levels of IL-1α in the cerebral cortex of mice: assessment with species-specific enzyme immunoassays , 1997, Journal of Neuroimmunology.
[76] T. Bártfai,et al. Cytokine Regulation of Neuronal Survival , 1992, Journal of neurochemistry.
[77] G. Calandra,et al. Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. , 1982, Arthritis and rheumatism.
[78] E. Benveniste,et al. Cytokine actions in the central nervous system. , 1998, Cytokine & growth factor reviews.
[79] R. Gomez-flores,et al. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[80] P. Deuster,et al. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. , 1997, The Journal of clinical endocrinology and metabolism.
[81] N. Rothwell,et al. Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.
[82] G. Chrousos,et al. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1988, Neuroendocrinology.
[83] L. Crofford,et al. Local Expression of Corticotropin‐Releasing Hormone in Inflammatory Arthritis , 1995, Annals of the New York Academy of Sciences.
[84] K. Madden,et al. Noradrenergic Sympathetic Innervation of Lymphoid Organs1 , 1988 .
[85] S. Lipton. Janus faces of NF-κB: Neurodestruction versus neuroprotection , 1997, Nature Medicine.
[86] P. Barnes,et al. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.
[87] Mellon Rd,et al. The Effects of Morphine, Nicotine and Epibatidine on Lymphocyte Activity and Hypothalamic-Pituitary-Adrenal Axis Responses , 1999 .